acute congestive heart failure उदाहरण वाक्य
उदाहरण वाक्य
- A Mountain View biotech firm cleared a key regulatory hurdle yesterday, but has one more test to pass before it wins final approval to sell a new drug to treat acute congestive heart failure.
- SAN FRANCISCO _ A Sunnyvale, Calif ., firm won U . S . Food and Drug Administration approval Monday for the first new treatment for acute congestive heart failure in more than a decade.
- In August, the U . S . Food and Drug Administration approved Natrecor, a genetically engineered version of a natural human protein known as B-type natriuretic peptide, for use in acute congestive heart failure.
- In the large-scale trial of patients with acute congestive heart failure, the drug, called NATRECOR, caused a statistically significant improvement in patients'symptoms as well as in two primary measures of the heart's overall functioning.
- If given final approval by the FDA, the drug, called Natrecor, would be the first new treatment for acute congestive heart failure in over a decade, according to Scios, which is based in Sunnyvale, Calif.
- Every year, acute congestive heart failure strikes an estimated 1 million people out of the nearly 4 million who suffer from chronic ongoing heart failure and is a leading cause of hospitalization in the U . S ., Casey said.